Abbott Laboratories Stock Analysis & AI Score
Abbott Laboratories (ABT) has an ST Score of 57.5 (B-), driven by its Sentiment (A+) and held back by its Financial Strength (D+). Analysts rate it Buy with a $119.91 price target (+16.8% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
AI Daily Briefing
Analysis by AIABT Stock Price History
ABT Technical Indicators
FMPEarnings Surprises
Analyst Forecast
Revenue Mix
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Devices |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NYSE |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Analyst Price Target
ESG Score
ABT Latest Stock News
ST Score
Abbott Laboratories (ABT) has an ST Score of 57.5 (B-), driven by its Sentiment (A+) and held back by its Financial Strength (D+). Analysts rate it Buy with a $119.91 price target (+16.8% upside).
- Strongest
- SentimentA+
- Weakest
- Financial StrengthD+
All factor grades
- SentimentA+
- ProfitabilityA
- ForecastB+
- MomentumB-
- GrowthC
- ValuationD+
- Financial StrengthD+
- Piotroski5/9
Press Releases
Company Contact Details
ABT stock: frequently asked questions
What is ABT's ST Score?
Abbott Laboratories (ABT) has an ST Score of 57.5 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is ABT a buy, hold, or sell?
Analysts rate ABT a Buy, with a price target of $119.91 (+16.8% vs the current price). Our ST Score grades it B- (57.5/100). The ST Score is a data-driven signal, not a recommendation.
What are ABT's factor grades?
Valuation D+, Profitability A, Financial Strength D+, Momentum B-, Growth C, Forecast B+, Sentiment A+.
What is ABT's valuation grade?
Abbott Laboratories (ABT) earns a valuation grade of D+, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is ABT's growth grade?
Abbott Laboratories (ABT) earns a growth grade of C, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is ABT's profitability grade?
Abbott Laboratories (ABT) earns a profitability grade of A, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is ABT's financial strength grade?
Abbott Laboratories (ABT) earns a financial strength grade of D+, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for ABT?
The average analyst price target for Abbott Laboratories (ABT) is $119.91 from 42 analysts, which is +16.8% versus the recent price of $102.70.
What is ABT's Piotroski score?
Abbott Laboratories (ABT) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.